Identification and initial validation of neuroendocrine differentiation as a novel prognostic factor in stage II colorectal cancer patients

Neuroendocrine differentiation is often found in colorectal cancer but its impact on prognosis remains controversial. This study explored the association between neuroendocrine differentiation and prognosis in stage II/III colorectal cancer patients.